AngioDynamics beat on sales and beat on earnings this morning -- sort of. The company reported a smaller-than-expected ...

Full Year 2025 Results Key Financial Results Revenue: US$292.5m (down 3.8% from FY ...

Q4 2025 Earnings Call Transcript July 15, 2025 AngioDynamics, Inc. beats earnings expectations. Reported EPS is $-0.03, expectations were $-0.13. Operator: Good morning, and welcome to the ...

A Capital Region manufacturer expects to continue growing its revenue over the next year, though its bottom line could take a ...

Gain insights into AngioDynamics' Q4 2025 earnings, highlighting 12% revenue growth, international expansion, Med Tech advances, and a strong FY26 outlook.

Analysts estimate that AngioDynamics will report an earnings per share (EPS) of $-0.12. Investors in AngioDynamics are eagerly awaiting the company's announcement, hoping for news of surpassing ...

AngioDynamics expects full-year results to range from a loss of 35 cents per share to a loss of 25 cents per share, with revenue in the range of $305 million to $310 million. AngioDynamics shares have ...

AngioDynamics now expects Med Tech revenue growth in the range of 14-16%, up from the earlier growth projection of 12-15% a year ago. Med Device revenue growth is projected to be flat.

The Motley Fool. DATE Tuesday, July 15, 2025 at 8:00 a.m. ET Read More: Earn up to $845 cash back this year just by changing ...

AngioDynamics, Inc. ( NASDAQ: ANGO) Q4 2025 Earnings Conference Call July 15, 2025 8:00 AM ET James C. Clemmer - CEO, President & Director Stephen A. Trowbridge - Executive VP & CFO ...